Case_id: case_316
Case_description: 
A 32-year-old woman presents to the physician because she feels depressed, has difficulty sleeping, has a poor appetite, and has had a problem concentrating for the past 3 months. During this time, she has also has had low energy and has lost interest in playing the guitar. During high school, the patient went through similar episodes of low mood and poor sleep. At that time, she would repeatedly engage in binge eating and purging behavior, for which she was referred to therapy. There is no evidence of suicidal ideation. Her physician offers to prescribe a medication for her current symptoms. Treatment with which of the following drugs should be avoided in this patient?
Options: 
1. Bupropion
2. Citalopram
3. Fluoxetine
4. Mirtazapine
5. Trazodone
Correct Answer: Bupropion

================================================================================
Launch the MCC process
================================================================================
GPT is reasoning the answer...

GPT's diagnostic conclusion:
Choice: Option 1 (Bupropion)

GPT's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- **Basic Information:** 32-year-old woman.  
- **Chief Complaint:** Persistent depressive symptoms lasting 3 months.  
- **Key Clinical Manifestations:** Depressed mood, difficulty sleeping (insomnia), poor appetite, poor concentration, low energy, and loss of interest in previously enjoyed activity (playing the guitar).  
- **Relevant History:** Similar depressive episodes during high school accompanied by binge eating and purging behaviors, for which she was referred to therapy. No current suicidal ideation.

**2. Analysis of Clinical Features**  
- **Depressive Symptoms:** The patient exhibits core features of Major Depressive Disorder (MDD) including depressed mood, anhedonia, sleep disturbances, appetite changes, fatigue, and concentration difficulties lasting more than two weeks.  
- **Chronicity and Recurrence:** The current episode has persisted for 3 months, and there is a history of similar episodes during adolescence, suggesting a recurrent pattern of depressive disorders.  
- **Comorbid Eating Disorder:** Past binge eating and purging behaviors indicate a possible comorbid eating disorder, such as Bulimia Nervosa or a Purging Type of an Eating Disorder Not Otherwise Specified (EDNOS).  
- **Safety Profile:** No suicidal ideation is present, which is important for medication selection regarding safety and monitoring.

**3. Differential Diagnosis Analysis**  
- **Option 1: Bupropion**  
  - **Analysis:** Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI) used to treat depression and aid in smoking cessation. However, it lowers the seizure threshold and is contraindicated in patients with a history of seizures, eating disorders involving binging and purging (e.g., Bulimia Nervosa), or those undergoing abrupt discontinuation of alcohol or benzodiazepines. Given the patient's history of binge eating and purging behaviors, bupropion poses an increased risk of seizures and should be avoided.

- **Option 2: Citalopram**  
  - **Analysis:** Citalopram is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for MDD and anxiety disorders. It is generally considered safe for patients with a history of eating disorders and does not carry the same seizure risk as bupropion.

- **Option 3: Fluoxetine**  
  - **Analysis:** Fluoxetine, another SSRI, is FDA-approved for both MDD and Bulimia Nervosa. It is suitable for patients with comorbid depressive and eating disorders.

- **Option 4: Mirtazapine**  
  - **Analysis:** Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA) effective in treating MDD. It is not contraindicated in patients with a history of eating disorders and may help with appetite stimulation.

- **Option 5: Trazodone**  
  - **Analysis:** Trazodone is an antidepressant primarily used to treat insomnia associated with depression. It does not carry specific contraindications related to eating disorders.

**4. Final Selection**  
**My final selection is: Option 1 (Bupropion) 布洛普酮**
================================================================================
Qwen is reasoning the answer...

Qwen's diagnostic conclusion:
Choice: Option 1 (Bupropion)

Qwen's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
A 32-year-old woman presents with a 3-month history of depressed mood, insomnia, poor appetite, concentration difficulties, low energy, and loss of interest in activities (e.g., playing the guitar). Her past history includes similar episodes of low mood and insomnia during high school, accompanied by binge eating and purging behaviors, for which she underwent therapy. There is no current evidence of suicidal ideation.  

**2. Analysis of Clinical Features**  
The patient’s current symptoms align with major depressive disorder (MDD), including depressed mood, anhedonia, sleep disturbance, and psychomotor retardation. Her past history of binge eating and purging suggests a prior diagnosis of bulimia nervosa. The absence of current binge/purge behaviors indicates that her current presentation is primarily depressive. However, her history of bulimia nervosa is critical because certain antidepressants may exacerbate eating disorder symptoms or pose specific risks.  

**3. Differential Diagnosis Analysis**  
- **Bupropion (Option 1):**  
  Bupropion is an NDRI with efficacy for depression and attention issues. However, it carries a risk of seizure induction, particularly in patients with risk factors such as electrolyte imbalances or low body weight. Patients with a history of eating disorders (e.g., bulimia nervosa) may have electrolyte disturbances or malnutrition, increasing seizure susceptibility. This places the patient at higher risk of bupropion-induced seizures, making it the most concerning option.  

- **Citalopram (Option 2):**  
  An SSRI with a well-established safety profile for depression. It is generally suitable unless contraindicated by QT prolongation risk (dose-dependent). No direct contraindication exists for prior bulimia nervosa.  

- **Fluoxetine (Option 3):**  
  An SSRI approved for both depression and bulimia nervosa. While it may suppress appetite, this aligns with the patient’s current anorexia symptoms. Fluoxetine is not contraindicated here, as her bulimia nervosa appears resolved, and it could even address residual eating disorder tendencies if present.  

- **Mirtazapine (Option 4):**  
  An NaSSA with appetite-stimulating properties, which may counteract her poor appetite. It has no specific contraindications related to eating disorder history.  

- **Trazodone (Option 5):**  
  A serotonin antagonist with sedative effects, useful for insomnia. It lacks direct contraindications for prior bulimia nervosa.  

**4. Final Selection**  
**My final selection is: Option 1 (Bupropion)(安非他酮)**  
The patient’s history of bulimia nervosa increases her risk of electrolyte imbalances or malnutrition, which can potentiate bupropion’s seizure risk. Bupropion’s association with seizures in vulnerable populations makes it the most inappropriate choice. Other options lack such direct contraindications and align better with her clinical presentation.
================================================================================
DeepSeek is reasoning the answer...

DeepSeek's diagnostic conclusion:
Choice: Option 1 (Bupropion)

DeepSeek's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- **Patient Profile**: 32-year-old woman.  
- **Chief Complaint**: Depressed mood, insomnia, poor appetite, poor concentration, low energy, and anhedonia (loss of interest in guitar) for 3 months.  
- **Key Clinical History**:  
  - Recurrent depressive episodes since adolescence.  
  - History of binge eating and purging behaviors during high school.  
  - No current suicidal ideation.  
- **Decisive Features**: Chronic depressive symptoms + history of binge-purge behavior.  

**2. Analysis of Clinical Features**  
- **Depressive Syndrome**: Symptoms meet criteria for major depressive disorder (MDD): low mood, anhedonia, sleep/appetite disturbances, fatigue, and impaired concentration.  
- **Eating Disorder History**: Past binge-purge behavior suggests a comorbid or resolved eating disorder (likely bulimia nervosa).  
- **Timeline**: Recurrent depressive episodes (since adolescence) with current exacerbation.  
- **Critical Red Flag**: History of purging behavior (electrolyte imbalances, metabolic instability) impacts medication safety.  

**3. Differential Diagnosis Analysis**  
1. **Bupropion**: Contraindicated in patients with eating disorders (bulimia/anorexia) due to increased seizure risk from electrolyte imbalances (hypokalemia/hyponatremia) caused by purging.  
2. **Citalopram (SSRI)**: Safe for MDD and reduces binge-purge behaviors. No specific contraindications here.  
3. **Fluoxetine (SSRI)**: First-line for MDD and FDA-approved for bulimia nervosa. Ideal given her history.  
4. **Mirtazapine**: Appetite-stimulating effects may help her poor appetite but no direct risk in eating disorders.  
5. **Trazodone**: Primarily used for insomnia; low-dose use is safe.  

**4. Final Selection**  
**My final selection is: Option 1 (Bupropion)(安非他酮)**  
- **Key Evidence**: Bupropion is contraindicated in patients with a history of purging behaviors due to its seizure risk. The patient’s binge-purge history and potential electrolyte imbalances make it unsafe. Other options (SSRIs, mirtazapine, trazodone) lack this specific risk.
================================================================================

The three models have reached an initial consensus!
Correct Answer: Option 1 (Bupropion)

GPT's initial diagnosis is correct
Qwen's initial diagnosis is correct
DeepSeek's initial diagnosis is correct

The three models have reached an initial consensus!All models selected Option1

========= Final Debate Result =========
GPT, Qwen, and DeepSeek-R1 have reached a consensus!
Final diagnosis: Option1 - Bupropion
Correct Answer: - Bupropion

Is the final diagnosis correct? ✓ Correct

